Clinical Trial Update: Sitagliptin Effects on Arterial Vasculature and Inflammation in Obesity [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating sitagliptin on arterial vasculature and inflammation in obesity has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Inflammation

Drugs mentioned

• Sitagliptin (sitagliptin)

Snippet

Sponsor: University of Southern California | Conditions: Atherosclerosis, Inflammation | Phase 2 | Status: COMPLETED